A team at Penn says it has slashed Car T cell therapy manufacturing timeframe to just 24 hours

The future of CAR T cell therapy research has come a long way over the years, but scientists have still been plagued by one problem: how to cut down on the timeframe, which typically takes between 9 and 14 days.

Except now. Researchers at Penn say that they have shortened the process, enhancing anti-tumor potency in just 24 hours. The preclinical study, carried out by researchers Michael Milone and Saba Ghassemi, has been published in Nature Biomedical Engineering.

Read the source article at endpts.com
2022-03-30 17:49:11